# Intranasal Oxytocin and Enhancement of Team Cohesion

> **NCT02302430** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 486 (actual)

## Conditions studied

- Unit Cohesion

## Interventions

- **DRUG:** Oxytocin
- **OTHER:** Placebo comparator

## Key facts

- **NCT ID:** NCT02302430
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2018-05
- **Final completion:** 2019-05-31
- **Target enrollment:** 486 (ACTUAL)
- **Last updated:** 2019-08-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02302430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02302430, "Intranasal Oxytocin and Enhancement of Team Cohesion". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02302430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*